Evidence map›Paper›PMID 23918145›Full record

ArticleDiabetologia2013

Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats.

Barbara A Mysona, Mohammed M H Al-Gayyar, Suraporn Matragoon, Mohammed A Abdelsaid, Mona F El-Azab, H Uri Saragovi, Azza B El-Remessy

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Bladder p75Life (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Observational
  6. Sortilin Inhibition Protects Neurons From Degeneration in the Diabetic Retina.Investigative ophthalmology & visual science · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Regulations of Retinal Inflammation: Focusing on Müller Glia.Frontiers in cell and developmental biology · 2022
    Review
  11. In vivo functions of p75Trends in pharmacological sciences · 2021
    Review
  12. Modulation of p75International journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Deletion of p75Scientific reports · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. p75Cell death & disease · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Barbara A MysonaProgram in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, 1120 15th Street HM-1200, Augusta, GA 30912, USA.
Mohammed M H Al-Gayyar
Suraporn Matragoon
Mohammed A Abdelsaid
Mona F El-Azab
H Uri Saragovi
Azza B El-Remessy
University of Georgia · USAugusta University · USCharlie Norwood VA Medical Center · USDiscovery Institute · USJewish General Hospital · CA

Funding

Molecular Mechanisms of diabetic retinopathyR01EY022408 · NEI · UNIVERSITY OF GEORGIA · PI EL-REMESSY, AZZA B · 2012 to 2016
$1.5M
NEI NIH HHS R01 EY022408NEI NIH HHS R01-EY022408
6 · The paper itself

Abstract

aims/hypothesisDiabetic retinopathy is characterised by early blood-retina barrier (BRB) breakdown and neurodegeneration. Diabetes causes imbalance of nerve growth factor (NGF), leading to accumulation of the NGF precursor (proNGF), as well as the NGF receptor, p75 neurotrophin receptor (p75(NTR)), suggesting a possible pathological role of the proNGF-p75(NTR) axis in the diabetic retina. To date, the role of this axis in diabetes-induced retinal inflammation and BRB breakdown has not been explored. We hypothesised that modulating p75(NTR) would prevent diabetes- and proNGF-induced retinal inflammation and BRB breakdown.

methodsDiabetes was induced by streptozotocin in wild-type and p75(NTR) knockout (p75KO) mice. After 5 weeks, the expression of inflammatory mediators, ganglion cell loss and BRB breakdown were determined. Cleavage-resistant proNGF was overexpressed in rodent retinas with and without p75(NTR) short hairpin RNA or with pharmacological inhibitors. In vitro, the effects of proNGF were investigated in retinal Müller glial cell line (rMC-1) and primary Müller cells.

resultsDeletion of p75(NTR) blunted the diabetes-induced decrease in retinal NGF expression and increases in proNGF, nuclear factor κB (NFκB), p-NFκB and TNF-α. Deletion of p75(NTR) also abrogated diabetes-induced glial fibrillary acidic protein expression, ganglion cell loss and vascular permeability. Inhibited expression or cleavage of p75(NTR) blunted proNGF-induced retinal inflammation and vascular permeability. In vitro, proNGF induced p75(NTR)-dependent production of inflammatory mediators in primary wild-type Müller and rMC-1 cultures, but not in p75KO Müller cells. CONCLUSIONS/

interpretationThe proNGF-p75(NTR) axis contributes to retinal inflammation and vascular dysfunction in the rodent diabetic retina. These findings underscore the importance of p75(NTR) as a novel regulator of inflammation and potential therapeutic target in diabetic retinopathy.

Indexed as

AnimalsBlood-Retinal BarrierBlotting, WesternCells, CulturedDiabetes Mellitus, ExperimentalDiabetic RetinopathyEnzyme-Linked Immunosorbent AssayKidneyMaleMiceMice, KnockoutRatsReal-Time Polymerase Chain ReactionReceptor, Nerve Growth FactorReceptor, Nerve Growth Factor

Identifiers

PMID23918145
PMCPMC3791887
OpenAlexW2074550903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.